UltraGreen.ai (ULG) Stock Overview
Manufactures fluorescence imaging surgical devices and pharmaceutical agents. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
ULG Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
UltraGreen.ai Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.44 |
| 52 Week High | US$1.62 |
| 52 Week Low | US$1.42 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -5.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| ULG | SG Medical Equipment | SG Market | |
|---|---|---|---|
| 7D | n/a | 3.6% | 0.04% |
| 1Y | n/a | -18.3% | 20.0% |
Return vs Industry: Insufficient data to determine how ULG performed against the SG Medical Equipment industry.
Return vs Market: Insufficient data to determine how ULG performed against the SG Market.
Price Volatility
| ULG volatility | |
|---|---|
| ULG Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in SG Market | 14.7% |
| 10% least volatile stocks in SG Market | 2.1% |
Stable Share Price: ULG's share price has been volatile over the past 3 months compared to the SG market.
Volatility Over Time: Insufficient data to determine ULG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2024 | 93 | Ravi Sajwan | ultragreen.ai |
UltraGreen.ai Limited manufactures fluorescence imaging surgical devices and pharmaceutical agents. Its products include indocyanine green, a fluorescent imaging agent used in FGS and ophthalmology; IC-Flow imaging system, a small, compact handheld NIR device that visualizes and records tissue fluorescence; fluorescein, an ophthalmic contrast agent for perfusion and abnormalities visualization ; and ephedrine, a medicine to increase blood pressure in surgeries. In addition, the company provides quantification software that allows real-time, quantitative perfusion assessment and tumor identification; UltraLinQ, an imaging software for visualization, and augmented reality glasses that projects real-time surgical images and virtual guidance for physicians.
UltraGreen.ai Limited Fundamentals Summary
| ULG fundamental statistics | |
|---|---|
| Market cap | US$1.59b |
| Earnings (TTM) | US$53.84m |
| Revenue (TTM) | US$126.55m |
Is ULG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ULG income statement (TTM) | |
|---|---|
| Revenue | US$126.55m |
| Cost of Revenue | US$19.27m |
| Gross Profit | US$107.28m |
| Other Expenses | US$53.44m |
| Earnings | US$53.84m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.049 |
| Gross Margin | 84.77% |
| Net Profit Margin | 42.55% |
| Debt/Equity Ratio | 1,023.8% |
How did ULG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/05 13:28 |
| End of Day Share Price | 2025/12/05 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
UltraGreen.ai Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Cheong | UOB Kay Hian Research Pte Ltd |